Literature DB >> 29734511

Factors associated with quality of life in facial melasma: a cross-sectional study.

C F Pollo1, L D B Miot2, S Meneguin1, H A Miot2.   

Abstract

BACKGROUND: Melasma is a common chronic focal hypermelanosis that affects photexposed areas as face, mainly in women at fertile age. It inflicts a significant impact in quality of life; nevertheless, quality of life scores (e.g. MELASQoL) are not strongly correlated with clinical severity (e.g. MASI) in facial melasma, suggesting that different factors can influence the perception of disease beyond the clinical extension or the intensity of pigmentation.
OBJECTIVES: To explore clinical and socio-demographic aspects that influences MELASQoL scores.
METHODS: Cross-sectional study enrolling 155 adults (>18 y.o.) with facial melasma. MELASQoL, MASI, clinical and demographic information were assessed. The associations among factors were explored by multivariable methods.
RESULTS: The mean (SD) age of the participants was 39 (8) years, and 134 (86%) were females. The correlation (Spearman's rho) between MELASQoL and MASI was 0.35 (P < 0.05). In a multivariate regression, MELASQoL score was associated (P ≤ 0.05) to MASI score (β = 0.6), lower income (β = 6.8), be single (β = 4.2) and low education level (β = 5.0). At multiple correspondence analysis, MASI, sex, marriage, education and income were associated with MELASQoL, as well as MASI was associated to skin phototypes, income and education level.
CONCLUSION: The perception of life quality impairment in melasma is influenced by low scholarly, low family income, single marital status and greater clinical severity.
© 2018 Society of Cosmetic Scientists and the Société Française de Cosmétologie.

Entities:  

Keywords:  MASI; MELASQoL; melasma; quality of life

Year:  2018        PMID: 29734511     DOI: 10.1111/ics.12464

Source DB:  PubMed          Journal:  Int J Cosmet Sci        ISSN: 0142-5463            Impact factor:   2.970


  4 in total

1.  Evaluating the quality of life among melasma patients using the MELASQoL scale: A systematic review and meta-analysis.

Authors:  Yuan Zhu; Xiaofang Zeng; Jieya Ying; Yujia Cai; Yu Qiu; Wenzhong Xiang
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

2.  Comparison of generic and specific instruments to assess the quality of life in patients with melasma.

Authors:  Silmara Meneguin; Ioana Bitencourt Mourão; Camila Fernandes Pollo; Helio Amante Miot; Miriane Garuzi; Cesar de Oliveira
Journal:  BMC Med Res Methodol       Date:  2022-04-20       Impact factor: 4.612

Review 3.  Update on Melasma-Part II: Treatment.

Authors:  Daniel P Cassiano; Ana Cláudia C Espósito; Carolina N da Silva; Paula B Lima; Joana A F Dias; Karime Hassun; Luciane D B Miot; Hélio A Miot; Ediléia Bagatin
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-29

4.  Profile of dermatological consultations in Brazil (2018).

Authors:  Hélio Amante Miot; Gerson de Oliveira Penna; Andréa Machado Coelho Ramos; Maria Lúcia Fernandes Penna; Sílvia Maria Schmidt; Flávio Barbosa Luz; Maria Auxiliadora Jeunon Sousa; Sérgio Luiz Lira Palma; José Antonio Sanches Junior
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.